Medicamen Biotech has informed about approval to the Issue & Allot 324000 Equity Shares at a price of Rs 618 per share (including a premium of Rs 608 each), in accordance with the SEBI (ICDR) Regulations, 2009 on Preferential Allotment basis to a promoter group and non promoter group/ Investors. Calling of an Extraordinary General Meeting, of the Company in relation to the Preferential Issue as aforesaid on 12th January, 2018.
The above information is a part of company’s filings submitted to BSE.
